Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMQARW2)

Drug Name
SCHEMBL16365841 Drug Info
Synonyms SCHEMBL16365841
Cross-matching ID
PubChem CID
86580571
TTD Drug ID
DMQARW2

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting BUB1 mitotic checkpoint serine/threonine kinase (BUB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
SCHEMBL16322760 DM3OB4T N. A. N. A. Patented [1]
SCHEMBL17766424 DMC7PTY N. A. N. A. Patented [1]
PMID24900824C2-1-1 DMOSMBZ Discovery agent N.A. Investigative [2]
PMID24900824C2-13-1 DM2FYUM Discovery agent N.A. Investigative [2]
PMID24900824C2-3-1 DMC5JAT Discovery agent N.A. Investigative [2]
PMID24900824C2-3-2 DMVP0Z9 Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
BUB1 mitotic checkpoint serine/threonine kinase (BUB1) TT78309 BUB1_HUMAN Inhibitor [1]

References

1 Substituted benzylpyrazoles. US9765058.
2 Novel cycloalkenepyrazoles as inhibitors of bub1 kinase. ACS Med Chem Lett. 2014 Feb 12;5(4):280-1.